DXC logo

DXC

DXC Technology Company

$13.54
-$1.74(-11.42%)
58
Overall
80
Value
54
Tech
42
Quality
Market Cap
$2.55B
Volume
2.28M
52W Range
$11.82 - $23.75
Target Price
$14.63

Latest News for DXC

DXC Technology Earnings Call: AI Pivot vs. Revenue Drag
TipRanks Auto-Generated Newsdesk3 days agoFeb 01, 2026

Dxc Technology Company (($DXC)) has held its Q3 earnings call. Read on for the main highlights of the call. DXC Technology Balances AI Ambition Wit......

Analysts Offer Insights on Technology Companies: DXC Technology (DXC) and KLA (KLAC)
Catie Powers4 days agoJan 31, 2026

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on DXC Technology (DXC – Research Report) and KLA (KL......

Dexus Convenience Retail REIT Extends On-Market Buy-Back for Another Year
TipRanks Australian Auto-Generated Newsdesk7 days agoJan 27, 2026

Dexus Convenience Retail REIT ( ($AU:DXC) ) has issued an update. Dexus Convenience Retail REIT has extended its on-market securities buy-back prog......

Analysts’ Top Healthcare Picks: Nurix Therapeutics (NRIX), Dexcom (DXCM)
Catie Powers13 days agoJan 22, 2026

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Nurix Therapeutics (NRIX – Research Report) and Dexc......

Analysts Offer Insights on Healthcare Companies: BillionToOne, Inc. Class A (BLLN) and Dexcom (DXCM)
Brian Anderson15 days agoJan 20, 2026

Analysts have been eager to weigh in on the Healthcare sector with new ratings on BillionToOne, Inc. Class A (BLLN – Research Report) and Dexcom (D......

Analysts’ Top Healthcare Picks: Praxis Precision Medicines (PRAX), Dexcom (DXCM)
Howard Kim21 days agoJan 13, 2026

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Praxis Precision Medicines (PRAX – Research Report),......

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Dexcom (DXCM) and Health Catalyst (HCAT)
Brian Anderson22 days agoJan 13, 2026

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ultragenyx Pharmaceutical (RARE – Research Report), ......

Analysts Offer Insights on Healthcare Companies: Cartesian Therapeutics (RNAC), Evolus (EOLS) and Dexcom (DXCM)
Christine Browna month agoJan 09, 2026

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cartesian Therapeutics (RNAC – Research Report), Evo......

RBC Capital Reaffirms Their Buy Rating on Dexcom (DXCM)
TipRanks Auto-Generated Intelligence Newsdeska month agoJan 09, 2026

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Dexcom on January 7 and set a price target of $85.00. The company’s shares close......

Wolfe Research Remains a Sell on DXC Technology (DXC)
TipRanks Auto-Generated Intelligence Newsdeska month agoJan 08, 2026

Wolfe Research analyst Darrin Peller maintained a Sell rating on DXC Technology today and set a price target of $14.00. Peller covers the Technolog......

News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 12 articles.

ABCD
1SymbolPriceChangeVol
2DXC$13.54-11.4%2.28M
3
4
5
6

Get DXC Technology Company Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.